Dynamic natural killer cell and T cell responses to influenza infection

K Frank, S Paust - Frontiers in cellular and infection microbiology, 2020 - frontiersin.org
Influenza viruses have perplexed scientists for over a hundred years. Yearly vaccines limit
their spread, but they do not prevent all infections. Therapeutic treatments for those …

A case for targeting Th17 cells and IL-17A in SARS-CoV-2 infections

M Orlov, PL Wander, ED Morrell… - The Journal of …, 2020 - journals.aai.org
Abstract SARS-CoV-2, the virus causing COVID-19, has infected millions and has caused
hundreds of thousands of fatalities. Risk factors for critical illness from SARS-CoV-2 infection …

Interleukin‐17—A multifaceted cytokine in viral infections

U Sahu, D Biswas, VK Prajapati… - Journal of Cellular …, 2021 - Wiley Online Library
Viral infections are a major threat to the human population due to the lack of selective
therapeutic measures. The morbidity and mortality reported worldwide are very alarming …

Immunopathology in influenza virus infection: uncoupling the friend from foe

D Damjanovic, CL Small, M Jeyananthan… - Clinical …, 2012 - Elsevier
Influenza epidemics and pandemics cause significant morbidity and mortality worldwide
associated with severe immunopathology in the lung, and the mechanisms of such …

[HTML][HTML] M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenza

SL Cole, J Dunning, WL Kok, KH Benam… - JCI insight, 2017 - ncbi.nlm.nih.gov
In each influenza season, a distinct group of young, otherwise healthy individuals with no
risk factors succumbs to life-threatening infection. To better understand the cause for this, we …

Influenza causes prolonged disruption of the alveolar-capillary barrier in mice unresponsive to mesenchymal stem cell therapy

JE Gotts, J Abbott, MA Matthay - American Journal of …, 2014 - journals.physiology.org
Viral pneumonia is a major cause of acute respiratory distress syndrome (ARDS). Anti-
inflammatory therapies for viral-induced lung injury show promise in preclinical models …

Severe influenza: overview in critically ill patients

C Sarda, P Palma, J Rello - Current opinion in critical care, 2019 - journals.lww.com
The present review summarizes current knowledge on pathogenesis and clinical
manifestations of severe influenza. Immunological dysfunction during viral infection …

New insights into the aryl hydrocarbon receptor as a modulator of host responses to infection

BP Lawrence, BA Vorderstrasse - Seminars in immunopathology, 2013 - Springer
The host response to infection is known to be influenced by many factors, including genetics,
nutritional status, age, as well as drug and chemical exposures. Recent advances reveal …

[HTML][HTML] STAT1 is required for suppression of type 17 immunity during influenza and bacterial superinfection

B Lee, R Gopal, ML Manni, KJ McHugh… - …, 2017 - journals.aai.org
Influenza is an annual, global healthcare concern. Secondary bacterial pneumonia is a
severe complication associated with primary influenza virus infection that often results in …

Host–virus interaction: How host cells defend against influenza a virus infection

Y Zhang, Z Xu, Y Cao - Viruses, 2020 - mdpi.com
Influenza A viruses (IAVs) are highly contagious pathogens infecting human and numerous
animals. The viruses cause millions of infection cases and thousands of deaths every year …